+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Carcinoma Drug"

2019 Recurrent Head And Neck Cancer Squamous Cell Carcinoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets - Product Thumbnail Image

2019 Recurrent Head And Neck Cancer Squamous Cell Carcinoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • Clinical Trials
  • February 2019
  • 116 Pages
From
2019 Head And Neck Carcinoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets - Product Thumbnail Image

2019 Head And Neck Carcinoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • Clinical Trials
  • February 2019
  • 403 Pages
From
2019 Thymic Carcinoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets - Product Thumbnail Image

2019 Thymic Carcinoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • Clinical Trials
  • February 2019
  • 76 Pages
From
2019 Verrucous Carcinoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets - Product Thumbnail Image

2019 Verrucous Carcinoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • Clinical Trials
  • February 2019
  • 43 Pages
From
2019 Squamous Cell Carcinoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets - Product Thumbnail Image

2019 Squamous Cell Carcinoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • Clinical Trials
  • February 2019
  • 507 Pages
From
Thymic Carcinoma R&D Pipeline Analysis Report, H2-2018 - Product Thumbnail Image

Thymic Carcinoma R&D Pipeline Analysis Report, H2-2018

  • Report
  • August 2018
  • 70 Pages
From
Metastatic Hepatocellular Carcinoma R&D Pipeline Analysis Report, H2-2018 - Product Thumbnail Image

Metastatic Hepatocellular Carcinoma R&D Pipeline Analysis Report, H2-2018

  • Report
  • August 2018
  • 100 Pages
From
Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H2 2018 - Product Thumbnail Image

Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H2 2018

  • Drug Pipelines
  • August 2018
  • 74 Pages
From
Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced In Hepatomas or SDF1 or Pre B Cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H2 2018 - Product Thumbnail Image

Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced In Hepatomas or SDF1 or Pre B Cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H2 2018

  • Drug Pipelines
  • August 2018
  • 63 Pages
From
Neuroendocrine Carcinoma Ongoing Global Clinical Trials Analysis and Outlook - Product Thumbnail Image

Neuroendocrine Carcinoma Ongoing Global Clinical Trials Analysis and Outlook

  • Report
  • June 2018
  • 84 Pages
From
Hepatocellular Carcinoma (HCC) - Epidemiology Forecast to 2027 - Product Thumbnail Image

Hepatocellular Carcinoma (HCC) - Epidemiology Forecast to 2027

  • Report
  • June 2018
  • 92 Pages
From
Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) - Pipeline Review, H1 2018 - Product Thumbnail Image

Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) - Pipeline Review, H1 2018

  • Drug Pipelines
  • May 2018
  • 42 Pages
From
Neuroendocrine Carcinoma Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Neuroendocrine Carcinoma Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • March 2018
  • 87 Pages
From
Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced In Hepatomas or SDF1 or Pre B Cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H1 2018 - Product Thumbnail Image

Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced In Hepatomas or SDF1 or Pre B Cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H1 2018

  • Drug Pipelines
  • February 2018
  • 61 Pages
From
Global CAR T Cell Therapy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026 - Product Thumbnail Image

Global CAR T Cell Therapy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

  • Report
  • February 2018
From
Loading Indicator
adroll